Cigna Group (CI) risk factors, FY2024 10-K

Cigna Group's FY2024 10-K, filed Feb 27, 2025, lists 31 risk factors in 2 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
312 groups
Section length
13k wordsItem 1A

Cigna Group's biggest risks in the FY2024 10-K

  • Cigna faces intense industry competition and price pressure across health services and pharmacy benefit management operations.
  • Substantial regulatory oversight governs government-sponsored programs, privacy laws, and pharmaceutical manufacturer rebates.
  • IT infrastructure stability and cybersecurity threats are critical operational dependencies for customer data.

The risks most specific to Cigna Group

  • Strategic and Operational Risks

    We face price competition and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers

    We face price competition and pressure to contain premium rates or administrative fees, which could compress our margins.

  • Strategic and Operational Risks

    If we lose our relationship with one or more key pharmaceutical manufacturers, or if the payments made or discounts provided by pharmaceutical manufacturers decline, our business and results of operations could be adversely affected

    Our business could be adversely affected if we lose key pharmaceutical manufacturer relationships or if rebates and fees decline.

  • Strategic and Operational Risks

    If significant changes occur within the pharmacy provider marketplace, or if other issues arise with respect to our pharmacy networks, including the loss of or adverse change in our relationship with one or more key pharmacy providers, our business and financial results could be adversely affected

    The ten largest retail pharmacy chains represent approximately 60% of our largest network, exposing us to risks from pharmacy provider changes.

  • Strategic and Operational Risks

    The costs to eliminate or address security threats and vulnerabilities before or after a cyber-incident could be significant. Our remediation efforts may not be successful and could result in interruptions, delays, or cessation of service and loss of customers

    Unauthorized access to private customer data could expose individuals to financial or medical identity theft and result in significant remediation costs.

  • Strategic and Operational Risks

    Our use of artificial intelligence and machine learning present regulatory and legal challenges that could negatively affect our business and our reputation

    Our use of artificial intelligence and machine learning presents regulatory and legal challenges that could negatively affect our business and reputation.

  • Legal and Compliance Risks

    There are various risks associated with participating in government-sponsored programs and providing services to payors who participate in government-sponsored programs, including dependence upon government funding, compliance with government contracts and increased regulatory oversight and enforcement

    We rely heavily on government-sponsored programs like Medicare and contracts with CMS and state agencies, subjecting us to increased funding and compliance risks.

  • Legal and Compliance Risks

    If we fail to comply with applicable privacy, security and data laws, regulations and standards, our business and reputation could be materially adversely affected

    We handle substantial personally identifiable information and protected health information, and failure to comply with privacy laws could harm our reputation.

  • Legal and Compliance Risks

    Significant stock market or interest rate declines could result in unfunded pension obligations resulting in the need for additional plan funding by us and increased pension expenses

    Significant stock market or interest rate declines could turn our frozen pension plan obligations unfunded, requiring additional plan funding.

  • Legal and Compliance Risks

    A downgrade in the financial strength ratings of our insurance subsidiaries could adversely affect new sales and retention of current business, and a downgrade in our debt ratings would increase the cost of borrowed funds and could negatively affect our ability to access capital

    A downgrade in our insurance subsidiaries' financial strength ratings or our debt ratings would increase borrowing costs and hurt sales.

All 31 risk factors

Headings as the filing states them, in filing order.

Strategic and Operational Risks

  1. 01Future performance of our business will depend on our ability to execute our strategic and operational initiatives effectively
  2. 02We operate in a highly competitive, evolving and rapidly changing industry, and our failure to adapt could negatively impact our business
  3. 03Our failure to anticipate or appropriately adapt to changes in the industry could negatively impact our competitive position and adversely affect our business and results of operations
  4. 04We face price competition and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers
  5. 05If we fail to develop and maintain satisfactory relationships with health care payors, physicians, hospitals and other health service providers and with producers and consultants, our business and results of operations may be adversely affected
  6. 06If we lose our relationship with one or more key pharmaceutical manufacturers, or if the payments made or discounts provided by pharmaceutical manufacturers decline, our business and results of operations could be adversely affected
  7. 07If significant changes occur within the pharmacy provider marketplace, or if other issues arise with respect to our pharmacy networks, including the loss of or adverse change in our relationship with one or more key pharmacy providers, our business and financial results could be adversely affected
  8. 08Changes in drug pricing or industry pricing benchmarks could materially impact our financial performance
  9. 09Our business depends on our ability to effectively invest in, implement improvements to and properly maintain the uninterrupted operation, availability and data integrity of our information technology and other business systems
  10. 10The costs to eliminate or address security threats and vulnerabilities before or after a cyber-incident could be significant. Our remediation efforts may not be successful and could result in interruptions, delays, or cessation of service and loss of customers
  11. 11Our use of artificial intelligence and machine learning present regulatory and legal challenges that could negatively affect our business and our reputation
  12. 12As a global company, we face political, legal, operational, regulatory, economic and other risks that present challenges and could negatively affect our multinational operations or our long-term growth
  13. 13These factors may increase in significance as we continue to expand globally, and operating in new foreign markets may require considerable management time before operations generate any significant revenues and earnings. Any one of these challenges could negatively affect our operations or long-term growth
  14. 14Strategic transactions involve risks and we may not realize the expected benefits because of integration or separation difficulties, underperformance relative to our expectations and other challenges, which could lead to an impairment charge
  15. 15Further, we may finance strategic transactions by issuing common stock for some or all of the purchase price that could dilute the ownership interests of our shareholders or by incurring additional debt that could increase costs and impact our ability to access capital in the future
  16. 16We are dependent on the success of our relationships with third parties for various services and functions
  17. 17A significant disruption in service within our operations or among our key suppliers or other third parties could materially adversely affect our business and results of operations
  18. 18In managing medical practices and operating pharmacies, onsite clinics and other types of medical facilities, we may be subject to additional liability that could result in significant time and expense

Legal and Compliance Risks

  1. 19Our business is subject to substantial government regulation, as well as new laws or regulations or changes in existing laws or regulations that could have a material adverse effect on our business, results of operations, financial condition and liquidity
  2. 20each other. Noncompliance with applicable regulations by us or our third-party vendors could have material adverse effects on our business, results of operations, financial condition, liquidity and reputation
  3. 21There are various risks associated with participating in government-sponsored programs and providing services to payors who participate in government-sponsored programs, including dependence upon government funding, compliance with government contracts and increased regulatory oversight and enforcement
  4. 22We face risks related to litigation, regulatory audits and investigations
  5. 23If we fail to comply with applicable privacy, security and data laws, regulations and standards, our business and reputation could be materially adversely affected
  6. 24and they vary across jurisdictions. In addition, more jurisdictions are regulating the transfer of data across borders, and domestic privacy and data protection laws are generally becoming more onerous
  7. 25Effective prevention, detection and control systems are critical to maintain regulatory compliance and prevent fraud; failure of these systems could adversely affect us
  8. 26Economic and market conditions affect the value of our financial instruments and the value of particular assets and liabilities, investment income and interest expense
  9. 27Significant stock market or interest rate declines could result in unfunded pension obligations resulting in the need for additional plan funding by us and increased pension expenses
  10. 28A downgrade in the financial strength ratings of our insurance subsidiaries could adversely affect new sales and retention of current business, and a downgrade in our debt ratings would increase the cost of borrowed funds and could negatively affect our ability to access capital
  11. 29Unfavorable developments in economic conditions may adversely affect our business, results of operations and financial condition
  12. 30The occurrence of these events have led, and may lead, to a decrease in our customer base, revenues or margins or an increase in our operating costs
  13. 31We are subject to the credit risk of our reinsurers

Other Cigna Group 10-Ks

  • FY2025 10-K risk factors
    29 risks7 new9 dropped16 reworded

    Competition risk now highlights telehealth, AI, new entrants, direct employer-provider contracting, drug pricing and distribution changes.

    Filed Feb 26, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.